(lp0
S'Cambrex Corporation  held by 34 SEC 13F Filers Post Analyst - 16 hours ago Cambrex Corporation  reached 33.94% versus a 1-year low price of $38.3. The stock was last seen 2.5% higher, reaching at $51.3 on Mar. 17, 2017.'
p1
aS'Stock Returns: Cambrex Corporation  versus PAREXEL International ... CML News - 11 hours ago This is a snapshot to compare the stock returns for Cambrex Corporation  versus PAREXEL International Corporation  .'
p2
aS'Cambrex Corporation: Exciting Time Ahead For This Biotech Company Seeking Alpha - Mar 24, 2016 Several months ago, I wrote a research article on Cambrex . The company has been growing impressively and just had a record year while the stock is up about 90% since 2015.'
p3
aS'Cambrex: A Pure Growth Play Seeking Alpha - Feb 15, 2017 Cambrex provides products and services for the development and commercialization of new and generic therapeutics. They operate in North America, Europe, and Asia.'
p4
aS"Claes Glassell Appointed to the Board of Directors of Cambrex Corporation GlobeNewswire  - Mar 16, 2016 EAST RUTHERFORD, N.J., March 16, 2016  -- Cambrex Corporation   announced today that on March 14, 2016, Claes Glassell was appointed to the Company's Board of Directors for a term expiring on the date&nbsp;..."
p5
aS'Cambrex Opens New Pilot Plant at Its Milan, Italy Site GlobeNewswire  - Oct 3, 2016 EAST RUTHERFORD, N.J., Oct. 03, 2016  -- Cambrex Corporation , the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients , today announced the validation and ISO&nbsp;...'
p6
aS'Cambrex Corporation Completes Expansion at Iowa Facility Pharmaceutical Technology Magazine   - Jul 19, 2016 Cambrex Corporation announced on July 12, 2016 the completion and validation of a $50-million production and warehousing expansion at its cGMP Charles City, Iowa site.'
p7
aS'Cambrex: Overblown Concerns Present Attractive Entry Opportunity Into Growing ... Seeking Alpha - Oct 3, 2016 The risk of a Gilead-driven downturn is already priced in and offers an attractive buying opportunity. Active Pharmaceutical Ingredients  volumes and outsourcing will increase, drug companies continue to favor high-quality US and European&nbsp;...'
p8
aS'Cambrex Corp.  to Acquire Privately-Held PharmaCore for ~$25M StreetInsider.com - Sep 26, 2016 Cambrex Corporation  agreed to acquire PharmaCore Inc., a privately-owned company specializing in developing, manufacturing and scaling up small molecule APIs for clinical phase projects, for approximately $25 million.Cambrex bolstering API services through $25m PharmaCore acquisition - In-PharmaTechnologist.com'
p9
aS'Cambrex Appoints Tom Vadaketh as Executive Vice President and Chief Financial ... GlobeNewswire  - Jan 4, 2017 EAST RUTHERFORD, N.J., Jan. 04, 2017  -- Cambrex Corporation , a leading manufacturer of small molecule Active Pharmaceutical Ingredients , today announced the hiring of Tom Vadaketh as Executive Vice&nbsp;...Cambrex creates new exec role to oversee strategy, hires CFO - NJBIZ'
p10
a.